Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 2/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22195501 | 0.91 | PRKDC (0.36) | PRKDCLIMK1ESR2ALOX5PIM1 | |
| SCHEMBL22195838 | 0.91 | PRKDC (0.36) | PRKDCLIMK1ESR2ALOX5PIM1 | |
| SCHEMBL22195443 | 0.91 | PRKDC (0.36) | PRKDCLIMK1ESR2ALOX5PIM1 | |
| SCHEMBL22195582 | 0.89 | PRKDC (0.35) | PRKDCLIMK1ESR2ALOX5PIM1 | |
| SCHEMBL22195583 | 0.89 | PRKDC (0.35) | PRKDCLIMK1ESR2ALOX5PIM1 | |
| SCHEMBL22196113 | 0.89 | PRKDC (0.36) | PRKDCLIMK1ESR2ALOX5 | |
| SCHEMBL22329444 | 0.89 | PRKDC (0.36) | PRKDCLIMK1ESR2ALOX5 | |
| SCHEMBL22196110 | 0.89 | PRKDC (0.36) | PRKDCLIMK1ESR2ALOX5 | |
| SCHEMBL22195740 | 0.88 | PRKDC (0.35) | PRKDCLIMK1ESR2ALOX5 | |
| SCHEMBL22195811 | 0.88 | PRKDC (0.36) | PRKDCESR2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128360-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY1, ORC3, ODC1 | PRKDC 4741/4885LIMK1 244/4885ESR2 1164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.